Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-311264
Filing Date
2021-10-28
Accepted
2021-10-28 16:01:57
Documents
9
Period of Report
2021-12-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d236296ddef14a.htm DEF 14A 396751
2 GRAPHIC g236296dsp2a.jpg GRAPHIC 5423
3 GRAPHIC g236296g03v42.jpg GRAPHIC 1966
4 GRAPHIC g236296g1005043456740.jpg GRAPHIC 1478
5 GRAPHIC g236296g1005043457396.jpg GRAPHIC 677
6 GRAPHIC g236296g1005043457646.jpg GRAPHIC 782
7 GRAPHIC g236296g29d60.jpg GRAPHIC 217127
8 GRAPHIC g236296g35x00.jpg GRAPHIC 152276
9 GRAPHIC g236296star.jpg GRAPHIC 776
  Complete submission text file 0001193125-21-311264.txt   923134
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-50484 | Film No.: 211358164
SIC: 2834 Pharmaceutical Preparations